Why LANXESS Fell Even As Sales Rose

If you had hesitated in late October 2025 and skipped topping up LANXESS on the back of fresh analyst targets and detailed earnings projections, that restraint spared you a sharp setback. Investors who held LANXESS over the past year are down 43.9%, including dividends. The result is clear. The real puzzle is which signals on regulation, competition, energy costs, and required P/E assumptions were already on record before that decline unfolded.

If the move has made LANXESS harder to judge, start where the gap is still open and scan 191 high quality undervalued stocks.

The Two Stories LANXESS Investors Were Weighing

The shares cost €21.06 at the start of the period, and anyone looking at LANXESS then had to choose which future felt more realistic.

The bullish story pointed to a Fair Value of €26.79, a price that would only make sense if assumptions such as 1.4% annual revenue growth and a future P/E of 277.8x played out.

The bearish view argued for a Fair Value of €17, tied to ideas like a 0.1% annual revenue decline risk and pressure from low cost Asian competitors.

What The LANXESS Results Put To The Test

LANXESS releasing Vulkanox 4060 as a 6PPD alternative supported the bullish idea that regulation could create openings for new products. Quarterly figures, however, pointed in the opposite direction. Revenue reached €1,561m in Q2 2026 compared with €1,466m a year earlier, yet the firm still reported a loss and net margin moved from -3.1% to -3.4%. The evidence pointed both ways.

The episode rested on one assumption. It was the belief that modest revenue growth and regulation friendly products would repair profitability in short order. When you assess another chemicals group, test that claim against net income and margin, not just new product launches or top line progress.

What LANXESS’s Current Price Already Assumes

LANXESS now trades at €11.73 after a 43.9% loss over the past year, with the selected Narrative’s Fair Value sitting above that level. The Narrative focuses on portfolio reshaping, cost work, and greener product lines as the levers that could reshape earnings quality.

Before treating the fall as a chance rather than a warning, a buyer today would need to believe those shifts can offset weak demand, high energy costs, and tough Chinese competition strongly enough to rebuild cash generation on a leaner asset base.

"Strategic portfolio optimization, including the divestiture of the urethane business, accelerated closure of high-cost, high-CO2 assets, and network consolidation, positions LANXESS to allocate capital toward higher-margin, resilient segments (e.g., specialty additives, consumer protection), which is likely to support margin expansion and more recurring earnings over time."

The price and this Narrative do not agree. → Uncover what this Narrative says LANXESS is actually worth

Where LANXESS Connects To Materials

LANXESS pulls you into chemicals, yet regulation and electrification push attention wider.

Electric vehicles, wind turbines, and advanced electronics all need dependable magnet materials. Without them, motors, drives, and sensors can lose efficiency and reliability.

Another business focuses on rare earth mining, processing, and magnet production, supported by policy incentives and extended contracts with major customers.

Policy backing and recycling projects give that operation a different risk mix than LANXESS. Its evolving position could reshape how critical materials eventually reach end markets.

The case is on the record, with the assumptions it rests on. → See the Narrative that values this company 72% above its price

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com